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Abstract
Introduction: Deregulated or excessive host immune responses contribute to the pathogenesis of sepsis. Toll-like
receptor (TLR) signaling pathways and their negative regulators play a pivotal role in the modulation of host
immune responses and the development of sepsis. The objective of this study was to investigate the association of
variants in the TLR signaling pathway genes and their negative regulator genes with susceptibility to sepsis in the
Chinese Han population.
Methods: Patients with severe sepsis (n = 378) and healthy control subjects (n = 390) were enrolled. Five genes,
namely TLR2, TLR4, TLR9, MyD88 and TOLLIP, were investigated for their association with sepsis susceptibility by a
tag single nucleotide polymorphism (SNP) strategy. Twelve tag SNPs were selected based on the data of Chinese
Han in Beijing from the HapMap project and genotyped by direct sequencing. The mRNA expression levels of
TOLLIP were determined using real-time quantitative Polymerase Chain Reaction (PCR) assays, and concentrations
of tumor necrosis factor alpha (TNF-a) and interleukin-6 (IL-6) were measured by enzyme-linked immunosorbent
assay (ELISA).
Results: Our results showed that the minor C-allele of rs5743867 in TOLLIP was significantly associated with the
decreased risk of sepsis (Padj = 0.00062, odds ratio (OR)adj = 0.71, 95% confidence interval (CI) 0.59 to 0.86) after
adjustment for covariates in multiple logistic regression analysis. A 3-SNP haplotype block harboring the associated
SNP rs5743867 also displayed strong association with omnibus test P value of 0.00049. Haplotype GTC showed a
protective role against sepsis (Padj = 0.0012), while haplotype GCT showed an increased risk for sepsis (Padj =
0.00092). After exposure to lipopolysaccharide (LPS), TOLLIP mRNA expression levels in peripheral blood
mononuclear cells (PBMCs) from homozygotes for the rs5743867C allele were significantly higher than in
heterozygotes and homozygotes for the rs5743867T allele (P = 0.013 and P = 0.01, respectively). Moreover, the
concentrations of TNF-a and IL-6 in culture supernatants were significantly lower in the subjects of rs5743867CC
genotype than in CT and TT genotype subjects (P = 0.016 and P = 0.003 for TNF-a; P = 0.01 and P = 0.002 for IL-6,
respectively).
Conclusions: Our findings indicated that the variants in TOLLIP were significantly associated with sepsis
susceptibility in the Chinese Han population.
Introduction
Despite continuous progress in the development of anti-
biotics and other supportive care therapies, sepsis
remains an unconquered challenge for clinicians and
has an unacceptably high mortality rate of 30% to 50%
for severe sepsis and septic shock [1,2]. The pathophy-
siology of sepsis involves highly complex interactions
between invading microorganisms, the innate and adap-
tive immune systems of the host, and multiple down-
stream events leading to organ dysfunction [3].
Numerous studies have suggested that individuals vary
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any medium, provided the original work is properly cited.in their responses to infection [4]. Currently, more and
more evidence shows that common genetic variants of
the innate and adaptive immune response pathway
genes play an important role in determining the sus-
ceptibility to and outcome of sepsis [5-10].
Toll-like receptors (TLRs), a family of immune recep-
tors, were recently reported to be involved in the recog-
nition of pathogen-associated molecular patterns and
the initiation of host immune responses [11]. In
humans, more than 10 functional TLRs have been iden-
tified [12]. Among them, TLR2, TLR4, and TLR9 have
b e e ne s t a b l i s h e dt op l a yak e yr o l ei nt h em e d i a t i o no f
systemic responses to invading pathogens during sepsis
[11,12]. After recognition of their respective ligands,
TLRs induce inflammatory reactions by the activation of
signaling pathways mediated by the adapter proteins
myeloid differentiation factor 88 (MyD88) and Toll/
interleukin-1 (IL-1)-receptor domain-containing adap-
ter-inducing interferon [12]. The immune response
initiated by TLRs is an important mechanism of defense
against pathogenic microorganisms. However, prolonged
and excessive activation of TLR signaling pathways con-
tributes to the pathogenesis of sepsis and organ injury.
TLR signaling and subsequent functions, therefore,
must be under tight negative regulation to maintain
immune response balance [13]. Recent studies have
indicated that several negative regulators of TLR signal-
ing pathways, including Toll-interacting protein (TOL-
LIP), inhibited TLR signaling pathway-mediated
inflammatory responses and restored immune system
balance. Inadequate production of these endogenous
negative regulators may also contribute to the patho-
genesis of sepsis [14].
Several single-nucleotide polymorphisms (SNPs) in the
TLR signaling pathway genes have been reported to
influence the production of inflammatory cytokines and
be associated with susceptibility to inflammatory dis-
eases [15]. In studies focusing on infection or sepsis,
associations have been described for SNPs in the TLR1
(rs5743551), TLR2 (rs5743708), TLR4 (rs4986790 and
rs4986791), TLR9 (rs5743836), IRAK1 (rs1059703), and
TIRAP genes (rs8177374 and rs7932766) [7,16-21].
However, no studies have addressed the impact of
genetic variants in TLR signaling pathways and negative
regulators on sepsis susceptibility in the Chinese Han
population.
Therefore, given the pivotal role of TLR signaling
pathways and their negative regulators in the develop-
ment of sepsis, we hypothesized that variants in genes
encoding components of the TLR signaling pathways
and their negative regulators might confer susceptibility
to sepsis. To test this hypothesis, we conducted a case
control study using a tag SNP approach to investigate
the association of variants in TLR2, TLR4, TLR9,
MyD88,a n dTOLLIP with susceptibility to sepsis in the
Chinese Han population. In addition, we performed
functional evaluation of the associated SNP.
Materials and methods
Study design and enrollment
The diagnosis of sepsis met the criteria recommended
by the American College of Chest Physicians and the
Society of Critical Care Medicine Consensus Conference
[ 2 2 ] .S e v e r es e p s i sw a sd e f i n e da ss e p s i si nc o m b i n a t i o n
with sepsis-induced acute organ dysfunction in at least
one organ. Acute organ dysfunction was defined as
Sequential Organ Failure Assessment (SOFA) scores of
more than 2 for the organ in question. The SOFA score
was calculated daily. Clinical and demographic data at
baseline, including Acute Physiology and Chronic
Health Evaluation (APACHE) II scores, previous health
status, source of infection, microbiology, and intensive
care unit mortality, were obtained after the patient met
severe sepsis criteria. Exclusion criteria included age
below 18 years, pregnancy, severe chronic respiratory
disease, severe chronic liver disease (defined as a Child-
Pugh score of greater than 10), malignancy, use of high-
dose immunosuppressive therapy, and AIDS. Sex- and
age-matched controls were selected from healthy blood
donors. Healthy controls were defined as individuals
without any recent acute illness, any chronic illness, or a
history of sepsis. To reduce the potential confounding
from ethnic backgrounds, only the Han Chinese popula-
tion was enrolled in this study. The study was approved
by the ethics committee of Zhongshan Hospital of
Fudan University (Shanghai, China) (record number
2006-23). Informed consent was obtained from subjects
or from their legal surrogates before enrollment.
Single-nucleotide polymorphism selection and
genotyping
A total of five candidate genes involved in TLR signaling
pathways and their negative regulators were selected on
the basis of known biological activity: TLR2, TLR4,
TLR9, MyD88,a n dTOLLIP. Tag SNPs were selected on
t h eb a s i so ft h ed a t ao ft h eC h i n e s eH a ni nB e i j i n g
(CHB) from the HapMap project phase II [23]. Tag
SNPs for each of the genes were selected separately. In
total, 12 tag SNPs in the five genes were selected by
Tagger within Haploview using the following tagging
criteria: pairwise tagging of the HapMap population
with r
2 of at least 0.8 and a minor allele frequency
(MAF) of at least 5%. Location and characterization of
all of the tested SNPs are listed in Table 1.
Genomic DNA was extracted from whole blood with a
FlexiGene DNA Kit (Qiagen, Hilden, Germany) in
accordance with the protocol of the manufacturer.
Genotyping was performed by direct sequencing.
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Biosystems BigDye (version 3.1) chemistry (Applied Bio-
systems, Foster City, CA, USA), and the sequences were
resolved with an ABI 3730 Genetic Analyzer. The pri-
mers and polymerase chain reaction (PCR) protocols
used are shown in Table S1 in Additional file 1. Ana-
lyses of the sequence traces were performed with the
Staden package and double-scored by a second operator.
Isolation and stimulation of cells from healthy subjects
Peripheral blood mononuclear cells (PBMCs) were
derived from healthy subjects by means of the Ficoll
gradient density centrifugation method. Isolated PBMCs
were plated at a density of 1 × 10
6 cells per milliliter in
24-well plates and cultured in RPMI 1640 medium with
10% fetal bovine saline at 37°C with 5% CO2.T h ec e l l s
were incubated for 6 hours in the presence or absence
of 100 ng/mL Escherichia coli 0111:B4 lipopolysacchar-
ide (LPS) (Sigma-Aldrich, St. Louis, MO, USA). After
incubation, supernatants and cell pellets were harvested
and stored at -80°C until use.
RNA purification and TOLLIP mRNA expression analysis
Total RNA was extracted with an RNeasy Mini kit (Qia-
gen). One hundred nanograms of RNA was used for
cDNA synthesis with a High-Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) in accordance
with the protocol of the manufacturer. The synthesized
cDNA was used for real-time PCR performed by SYBR
green-based assay on an ABI 7900HT system (Applied
Biosystems). The primers for the TOLLIP gene were for-
ward 5’-CGGTGTACATCGGTGAGC-3’ and reverse
5’-CGTCTCGTACACCGCGTAG-3’.T h ep r i m e r sf o r
the endogenous control gene glyceraldehyde-3-phos-
phate dehydrogenase (GAPDH)w e r ef o r w a r d5 ’-
AAGGTCG GAGTCAACGGATT-3’ and reverse 5’-
CTCCTGGAA GATGGTGATGG-3’.W ec a r r i e do u t
initial denaturation at 95°C for 10 seconds followed by
40 cycles of PCR (95°C for 5 seconds, 57°C for 30 sec-
onds, and 72°C for 30 seconds). TOLLIP mRNA expres-
sion levels were normalized to the levels of GAPDH.A l l
experiments were run in triplicate. Independent cDNA
synthesis was carried out twice.
Measurement of tumor necrosis factor-alpha and
interleukin-6 levels
Concentrations of tumor necrosis factor-alpha (TNF-a)
and IL-6 in culture supernatants were measured with a
human enzyme-linked immunosorbent assay (ELISA) kit
(R&D Systems, Inc., Minneapolis, MN, USA) in accor-
dance with the protocol of the manufacturer.
Statistical analysis
The demographic variables between different groups
were compared by chi-square test for categorical vari-
ables. The genotype data were analyzed for deviations
from Hardy-Weinberg equilibrium by the Haploview
version 4.1 software [24]. The differences of allele and
genotype distributions between the sepsis and healthy
control groups were compared with the chi-square test
or Fisher’s exact test when appropriate. P values for gen-
otypic distributions were calculated with the global gen-
otype test. Allele frequencies of cases and controls were
used to calculate the odds ratio (OR) and the 95%
Table 1 Characteristics of the genotyped single-nucleotide polymorphisms in the genes of Toll-like receptor signaling
pathways and negative regulators
Gene Location SNP SNP type Major/minor allele MAF HWE P value
TLR2 4q32 rs1898830 Tag SNP, intron A/G 0.45 0.35
rs3804099 Tag SNP, exon T/C 0.32 0.64
TLR4 9q32-q33 rs2149356 Tag SNP, intron G/T 0.39 0.76
rs11536879 Tag SNP, intron A/G 0.16 0.47
rs1927907 Tag SNP, intron C/T 0.24 1.00
TLR9 3p21.3 rs352140 Tag SNP, exon G/A 0.38 1.00
MyD88 3p22 rs7744 Tag SNP, 3’ UTR A/G 0.38 0.41
rs6853 Tag SNP, 3’ UTR A/G 0.01 1.00
TOLLIP 11p15.5 rs3750920 Tag SNP, exon G/A 0.28 0.57
rs5743867 Tag SNP, intron T/C 0.35 0.61
rs3793964 Tag SNP, intron A/G 0.37 0.07
rs3793963 Intron G/A 0.25 0.30
rs5744002 Intron G/A 0.33 1.00
rs5743942 Tag SNP, intron T/C 0.12 1.00
rs5743944 Intron G/A 0.26 0.87
rs5743947 Intron G/A 0.31 0.53
HWE, Hardy-Weinberg equilibrium; MAF, minor allele frequency; MyD88, myeloid differentiation factor 88; SNP, single-nucleotide polymorphism; TLR, Toll-like
receptor; TOLLIP, Toll-interacting protein; UTR, untranslated region.
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was used to adjust for potential confounding factors,
including age and gender. Block was determined by
Haploview version 4.1 with a linkage disequilibrium
(LD)-based partitioning algorithm [25]. The data of the
observed blocks were analyzed with the omnibus test
and haplotype-specific association statistics (T test) as
implemented in PLINK [26]. The case/control omnibus
test was an H-1 degree of freedom test, in which H was
the number of different haplotypes. The Bonferroni
method was used to correct for multiple comparisons
where applicable. A two-tailed P value of less than 0.05
was considered statistically significant, whereas a value
of corrected P of less than (0.05 divided by the number
of tests) was considered significant after Bonferroni cor-
rection. Differences in relative mRNA expression and
TNF-a and IL-6 levels between genotypes were evalu-
ated by one-way analysis of variance (ANOVA). When a
significant difference was obtained in ANOVA, post hoc
comparison with the least significant difference test was
used to identify specific group differences. The software
used for statistical calculations was the SPSS 15.0 (SPSS,
Inc., Chicago, IL, USA) unless specified otherwise.
Results
Characteristics of the study population
From February 2006 to November 2009, 378 patients
with severe sepsis were enrolled in this case control
study. An additional population of 390 ethnicity-
matched healthy volunteers was recruited for compari-
son. The baseline characteristics and clinical data of all
subjects are shown in Table 2. The mean ages were 64.1
years for patients with severe sepsis and 65.8 years for
healthy controls (P > 0.05). The proportions of males
were 58.2% in patients with severe sepsis and 57.9% in
healthy controls (P > 0.05). The primary sources of
infection were the lungs (85.4%), followed by abdomen
(6.1%), blood stream (3.2%), urinary tract (2.9%), and
others (2.4%). The overall 30-day mortality rate of
patients with severe sepsis was 32.3%.
Association analyses of TLR2, TLR4, TLR9, MyD88, and
TOLLIP polymorphisms with susceptibility to sepsis
All of the 12 tag SNPs were genotyped successfully by
direct sequencing. Four other SNPs located in the intron
region of TOLLIP (rs3793963, rs5744002, rs5743944, and
rs5743947) were identified in the process of sequencing
(Table 1). The genotyping success rates ranged from
97.5% to 99%, and all of the genotype distributions were
consistent with Hardy-Weinberg equilibrium (P > 0.05)
(Table 1). The allele and genotype distributions of these
SNPs in healthy controls and patients with sepsis are
listed in Table 3 and in Table S2 in Additional file 1.
When patients with sepsis were compared with healthy
controls, two tag SNPs in TOLLIP were observed in asso-
ciation with sepsis susceptibility. The minor allele C of
rs5743867 in TOLLIP was associated with a decreased
risk of sepsis (P = 0.00016, OR = 0.67, 95% CI 0.54 to
0.82), and the significance remained present after Bonfer-
roni correction (P = 0.0026 corrected for 16 SNPs tested).
Furthermore, in multivariate logistic analyses adjusting
for age and gender, the rs574386 C allele was still signifi-
cantly associated with protection from sepsis (Padj =
0.00062, ORadj = 0.71, 95% CI 0.59 to 0.86). The genotype
distribution of rs5743867 was also significantly different
between sepsis and control groups (P =0 . 0 0 1 ) ,a n dt h e
difference remained significant after adjustment for age
and gender in multiple logistic regression analysis (Padj =
0.0018) and for multiple comparisons (P = 0.016 cor-
rected for 16 SNPs tested). SNP rs5743942 of TOLLIP
also showed an association with sepsis susceptibility. The
C allele of rs5743942 was associated with increased risk
of sepsis (Padj = 0.034, ORadj = 1.40, 95% CI 1.03 to 1.88).
Also, the genotype distribution was significantly different
between sepsis and control groups (Padj = 0.016). How-
ever, the difference was not significant after Bonferroni
correction (P > 0.05 corrected for 16 SNPs tested). Both
allele and genotype distributions of the other 14 SNPs in
Table 2 Demographic and clinical characteristics of the
study subjects
Healthy controls Patients with sepsis
Number 390 378
Age, years 65.8 ± 12.2 64.1 ± 12.6
Males/Females 226/164 220/158
APACHE II score NA 18.3 ± 4.3
Survival NA 67.7%
Length of ICU stay, days NA 18.6 ± 5.6
Diabetes NA 39 (10.3%)
Chronic liver disease NA 12 (3.2%)
Chronic renal failure NA 16 (4.2%)
Congestive heart failure NA 23 (6.1%)
Chronic pulmonary disease NA 31 (8.2%)
Sepsis insult
Lung NA 323 (85.4%)
Abdomen NA 23 (6.1%)
Bloodstream NA 12 (3.2%)
Urinary tract infection NA 11 (2.9%)
Others NA 9 (2.4%)
Microbiology positive NA 159 (42.1%)
Gram-positive NA 61 (38.4%)
Gram-negative NA 65 (40.9%)
Fungi NA 15 (9.4%)
Mixed NA 18 (11.3%)
Microbiology unknown NA 219 (57.9%)
APACHE II, Acute Physiology and Chronic Health Evaluation II; ICU, intensive
care unit; NA, not applicable.
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significantly between sepsis patients and healthy controls
(Table S2 in Additional file 1). Because TLRs detect spe-
cific microbial components, we performed the association
analyses of TLR2 and TLR9 with Gram-positive sepsis
patients and TLR4 and TLR9 with Gram-negative sepsis
patients. However, no significant difference was found
(Tables S3 and S4 in Additional file 1).
Association analyses of TOLLIP, TLR2, TLR4, TLR9, and
MyD88 haplotypes with susceptibility to sepsis
We then performed haplotype analysis to investigate
whether the haplotypes in the five genes were associated
with sepsis risk. Two haplotype blocks in the TOLLIP
region were determined by Haploview with an LD-based
partitioning algorithm (Figure 1). Block 1 contained four
SNPs (rs5744002, rs3793963, rs3793964, and rs3750920)
spanning 8 kb on the upstream region of TOLLIP,
which generated three common haplotypes with a fre-
quency of greater than 5%: GGAG, AAGA, and GGGG.
In the global test, haplotypes in this block were not sig-
nificantly associated with sepsis risk (Padj = 0.244). The
haplotype GGAG in this block was associated
with decreased risk of sepsis with borderline significance
(Padj =0 . 0 4 1 )( T a b l e4 )b u tt h ea s s o c i a t i o nw a sn o ts i g -
nificant after correction for multiple testing. Block 2
Table 3 Association analysis of the eight single-nucleotide polymorphisms in TOLLIP between sepsis patients and
healthy control subjects
Allelic comparison Genotypic comparison
SNP Control Sepsis PP adj OR (95% CI) ORadj (95% CI) PP adj
rs3750920
AA 29 (7.5%) 26(7.0%)
AG 159 (41.3%) 160 (43.1%)
GG 197 (51.2%) 185 (49.9%) 0.867 0.972 1.02 (0.82-1.27) 1.01 (0.72-1.38) 0.867 0.911
rs5743867
CC 64 (16.6%) 32 (8.6%)
CT 176 (45.7%) 161 (43.3%)
TT 145 (37.7%) 179 (48.1%) 0.00016 0.00062 0.67 (0.54-0.82) 0.71 (0.59-0.86) 0.001 0.0018
rs3793964
GG 39 (10.2%) 41 (11.1%)
AG 196 (51.0%) 210 (56.6%)
AA 149 (38.8%) 120 (32.3%) 0.140 0.251 1.17 (0.95-1.44) 1.09 (0.82-1.39) 0.179 0.280
rs3793963
AA 18 (4.7%) 22 (5.9%)
AG 151 (39.4%) 145 (39.1%)
GG 214 (55.9%) 204 (55.0%) 0.635 0.664 1.06 (0.84-1.37) 1.04 (0.81-1.29) 0.752 0.794
rs5744002
AA 42 (10.9%) 35 (9.5%)
AG 161 (41.9%) 175 (47.4%)
GG 181 (47.2%) 159 (43.1%) 0.591 0.694 1.06 (0.86-1.32) 1.02 (0.84-1.26) 0.752 0.810
rs5743942
CC 6 (1.6%) 4 (1.1%)
CT 65 (16.8%) 95 (25.5%)
TT 315 (81.6%) 274 (73.4%) 0.021 0.034 1.45 (1.06-1.98) 1.40 (1.03-1.88) 0.013 0.016
rs5743944
AA 19 (4.9%) 32 (8.7%)
AG 156 (40.5%) 131 (35.4%)
GG 210 (54.6%) 207 (55.9%) 0.607 0.642 1.06 (0.84-1.34) 1.03 (0.81-1.30) 0.074 0.102
rs5743947
AA 33 (8.6%) 34 (9.2%)
AG 157 (41.0%) 177 (47.8%)
GG 193 (50.4%) 159 (43.0%) 0.094 0.302 1.21 (0.97-1.50) 1.05 (0.85-1.31) 0.118 0.231
Data are presented as number (percentage) of subjects. P was determined using the chi-square test. P value adjusted for age and gender (Padj) came from
multivariate logistic regression. A P value of less than 0.003 (0.05/16) was considered statistically significant after Bonferroni correction. Rs5743867 remained
significant after Bonferroni correction. CI, confidence interval; OR, odds ratio; ORadj, odds ratio adjusted for age and gender; SNP, single-nucleotide polymorphism;
TOLLIP, Toll-interacting protein.
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rs5743867) spanning 14 kb on the downstream region
of TOLLIP, which generated four haplotypes with a fre-
quency of greater than 5%: GTC, GTT, ATT, and GCT.
A global test showed a significant difference between
sepsis and control groups, with a Padj value of 0.00049.
Among these haplotypes, the haplotype GTC appeared
protective and the frequency in the sepsis group was
lower than in the healthy control group (Padj = 0.0012,
ORadj = 0.73, 95% CI 0.62 to 0.89) (Table 4). Another
haplotype, GCT, was significantly associated with
increased risk of sepsis, and carriers of the GCT haplo-
type had a 1.62-fold increased risk for sepsis (Padj =
0.00092). No haplotypes in TLR2, TRL4, TLR9,a n d
MyD88 were associated with sepsis risk in this study
(data not shown).
Association analyses of TOLLIP mRNA expression level
with rs5743867 genotypes
We then evaluated the association between rs5743867
genotype and TOLLIP mRNA expression to determine
whether the above SNP association reflected cis-acting
regulatory effects on TOLLIP. A total of 38 healthy sub-
jects were enrolled to determine the amount of TOLLIP
mRNA expression level: 6 subjects with rs5743867CC
genotype, 18 subjects with rs5743867CT genotype, and
14 subjects with rs5743867TT genotype. As shown in
Figure 2, no significant difference in TOLLIP mRNA
expression was observed among CC, CT, and TT geno-
types in the unstimulated PBMCs (P > 0.05). After sti-
mulation with LPS for 6 hours, the TOLLIP mRNA
expression in PBMCs was significantly higher in CC
homozygotes compared with both CT heterozygotes and
TT homozygotes (P = 0.013 and P =0 . 0 1 ,r e s p e c t i v e l y ) ,
whereas the difference between the CT and TT groups
was not statistically significant (P = 0.779).
Association analyses of tumor necrosis factor-alpha and
interleukin-6 levels with rs5743867 genotypes
Because TOLLIP is involved in the cytokine processing,
we also evaluated whether the variant influences TNF-a
and IL-6 production (Figure 3). We observed a signifi-
cant association between TNF-a and IL-6 levels and
rs5743867 genotypes under the LPS-stimulated condi-
tion. Subjects with homozygotes for the rs5743867C
allele were associated with lower levels of TNF-a and
Figure 1 Linkage disequilibrium (LD) plot of eight single-
nucleotide polymorphisms in Toll-interacting protein (TOLLIP)
genotyped in this study. The plot was constructed with the
Haploview program [24], and r
2 (×100) values are depicted in the
diamonds. Blocks were determined by Haploview with an LD-based
partitioning algorithm [25]. The LD color scheme was stratified
according to the logarithm of the odds (LOD) score and D’: white,
D’ = 1 and LOD score = 2; pink or light red, D’ = 1 and LOD score
≥2; and bright red, D’ = 1 and LOD score ≥2.
Table 4 Associations between TOLLIP haplotypes and sepsis susceptibility
Frequency
LD block Haplotype
a Healthy control Sepsis P value Padj value OR (95% CI) ORadj (95% CI)
Block 1
b Global test 0.127 0.244
GGAG 0.615 0.558 0.027 0.041 0.79 (0.65-0.97) 0.86 (0.72-0.98)
AAGA 0.225 0.215 0.636 0.768 0.94 (0.74-1.20) 0.98 (0.80-1.44)
GGGG 0.060 0.083 0.088 0.177 1.41 (0.95-2.10) 1.03 (0.80-2.32)
Block 2
c Global test 0.00018 0.00049
GTC 0.380 0.299 0.00085 0.0012 0.69 (0.56-0.86) 0.73 (0.62-0.89)
GTT 0.283 0.302 0.399 0.424 1.10 (0.88-1.38) 1.06 (0.80-1.34)
ATT 0.248 0.261 0.590 0.778 1.07 (0.85-1.35) 1.02 (0.79-1.32)
GCT 0.076 0.134 0.00028 0.00092 1.87 (1.33-2.63) 1.62 (1.27-2.86)
A P value of less than 0.013 (0.05/4) was considered statistically significant after Bonferroni correction. Haplotype GTC and GCT in block 2 remained significant
after Bonferroni correction.
aHaplotype frequencies of less than 5% were not included in the analyses;
bthe order of polymorphisms was rs5744002, rs3793963,
rs3793964, and rs3750920;
cthe order of polymorphisms was rs5743944, rs5743942, and rs5743867. CI, confidence interval; LD, linkage disequilibrium; OR, odds
ratio; ORadj, odds ratio adjusted for age and gender; Padj, P value adjusted for age and gender; TOLLIP, Toll-interacting protein.
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the rs5743867T allele after LPS stimulation (P =0 . 0 1 6
and P = 0.003 for TNF-a; P =0 . 0 1a n dP = 0.002 for
IL-6, respectively). However, no significant association
was observed between TNF-a and IL-6 levels and
rs5743867 genotype under the unstimulated condition
(P > 0.05).
Discussion
T h i sw a st h ef i r s tr e p o r to ng e n etic association analysis
of TLR signaling pathways and their negative regulatory
genes in Chinese Han patients with sepsis. Sixteen SNPs
in five genes were successfully genotyped in this study.
Our results showed that a tag SNP rs5743867 in TOL-
LIP, which influences the expression of TOLLIP mRNA
and the production of TNF-a and IL-6, was significantly
associated with susceptibility to sepsis. Consistent with
the single SNP analyses, a three-SNP haplotype block
harboring the associated SNP rs5743867 was also asso-
ciated with the risk of sepsis.
The TLR signaling pathways and their negative regula-
tors play a critical role in the pathogenesis of sepsis.
Although several variants in the TLR signaling pathway
genes have been implicated in susceptibility to sepsis and
infectious diseases [7,16-20], the effect of variants in the
negative regulatory genes of TLR signaling pathways on
sepsis susceptibility has never been reported. We demon-
strated here the first evidence for an association of sepsis
susceptibility with variants in TOLLIP. TOLLIP, a nega-
tive regulator affecting cytoplasmic signal transduction, is
widely expressed in a variety of human tissues. The inhi-
bitory action of TOLLIP is mediated via suppression of
autophosphorylation and kinase activity of IL-1 receptor-
associated kinase 1, which is an important mediator in
the TLR signal transduction [27]. Transfection of TOL-
LIP in intestinal epithelial cells resulted in decreased
Figure 2 Association results between Toll-interacting protein (TOLLIP) gene expression levels and rs5743867 genotypes. Expression
levels of TOLLIP in peripheral blood mononuclear cells were normalized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH) expression
and are presented as the median, interquartile range, and extremes. The mRNA expression levels of TOLLIP were significantly different among CC,
CT, and TT genotypes under the lipopolysaccharide (LPS)-stimulated condition (P = 0.023, analysis of variance). No significant difference in TOLLIP
mRNA expression levels was observed among CC, CT, and TT genotypes under the unstimulated condition (P = 0.156, analysis of variance).
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acid. Moreover, the production of inflammatory cyto-
kines in TOLLIP-deficient mice, in comparison with that
of wild-type mice, was significantly reduced [28].
The in vitro expression assays of mRNA and produc-
tion of TNF-a and IL-6 in PBMCs under the LPS-stimu-
lated condition clarified the functional relevance of SNP
rs5743867 in TOLLIP. Subjects who were homozygotes
with the C allele had higher mRNA expression of TOL-
LIP and lower levels of TNF-a and IL-6. These results
indicated that SNP rs5743867 influenced the expression
of TOLLIP and subsequently decreased the production of
inflammatory cytokines. Rs5743867 is located in the
intron region of TOLLIP. This is in accordance with the
recent findings from genome-wide association studies
that most of the associated variants of complex diseases
are located outside the coding regions [29]. However, it is
currently unclear how an intronic polymorphism can
induce a phenotypic change. Rs5743867 may induce exon
skipping, enhance the use of cryptic splice sites, or alter
the ratio of alternatively spliced isoforms. Additionally,
rs5743867 is more likely a marker in LD with a regula-
tory region polymorphism that controls expression levels
of TOLLIP or a functional coding region SNP that influ-
ences the biological effect of TOLLIP. Exhaustive re-
sequencing is needed to find or rule out the possibility of
an as-yet-unidentified causal SNP in LD with rs5743867,
and further functional evaluation of novel or associated
SNPs is also needed.
To our knowledge, only two reports in the literature
have described associations between TOLLIP variants
and human diseases. Schimming and colleagues [30]
demonstrated that the -526G/C (rs5743854) polymorph-
ism in the promoter region of TOLLIP is significantly
associated with the susceptibility of atopic dermatitis,
which is a common inflammatory skin disorder. How-
ever, the mRNA expression of TOLLIP in lymphoid cells
was not significantly different between the genotypes of
rs5743854 [30]. Another study, conducted in 2008 by
Wurfel and colleagues [7], screened SNPs in 43 TLR-
related genes and identified one SNP (rs5743856) in
TOLLIP affecting TLR-mediated inflammatory response.
However, no study about the association between this
functional polymorphism and sepsis susceptibility was
reported. In our study, these two polymorphisms were
not genotyped, because they were not included in the
HapMap CHB data. Future study of TOLLIP should
consider these functional variants.
Our results also indicated that tag SNPs of TLR2,
TLR4, TLR9,a n dMyD88 did not represent major risk
factors for sepsis development. Two nonsynonymous
TLR4 SNPs (rs4986790 and rs4986791) have been
shown to be associated with sepsis and infectious dis-
eases in Caucasians and Africans. In another project
(data not shown here), we observed that rs4986790 and
rs4986791 are absent in Han Chinese populations, and
this finding is in agreement with reports from other
Asian populations [19,31,32]. Until now, no other SNPs
Figure 3 Association results between tumor necrosis factor-alpha (TNF-a) and interleukin-6 (IL-6) levels and rs5743867 genotypes.
Concentrations of TNF-a and IL-6 in culture supernatants are presented as the median, interquartile range, and extremes. The TNF-a and IL-6
levels were significantly different among CC, CT, and TT genotypes under the lipopolysaccharide (LPS)-stimulated condition (P = 0.01, P = 0.012,
analysis of variance). No significant difference in TNF-a and IL-6 levels was observed among CC, CT, and TT genotypes under the unstimulated
condition (P = 0.528, P = 0.209, analysis of variance).
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the susceptibility of sepsis or infectious diseases among
Asian populations. It was reported that polymorphisms
in TLR2 and TLR9 were associated with tuberculosis
and other infectious diseases in previous studies; how-
ever, no association with sepsis susceptibility was found
in our study [33,34]. One reason for these inconsisten-
cies could be explained by the fact that the spectrum of
infectious pathogens in our study was different from
that of previous studies.
There were several limitations in our study. First, the
association needs to be replicated in independent stu-
dies. Further replication studies in other populations are
also expected. Second, we did not re-sequence the gene
and instead used publicly available SNP databases. Thus,
some variants could have been missed because of the
incompleteness of these databases. Additionally, we did
n o te v a l u a t ew h e t h e rt h ee x p r e s s i o nl e v e l so fTOLLIP
are different between septic and non-septic patients.
Conclusions
In our study, genetic and expression evidence indicated
that a tag SNP in the intron region of TOLLIP was asso-
ciated with sepsis susceptibility in the Chinese Han popu-
lation by influencing the expression levels. These data
supported the concept that genetic variation in the nega-
tive regulators of TLR signaling pathways plays an impor-
tant role in the development of sepsis. Of note, whether
the genetic variation is associated with sepsis susceptibil-
ity in other populations still needs to be explored.
Key messages
￿ Individuals carrying the T allele of rs5743867 and
haplotype GCT in Toll-interacting protein (TOLLIP)
gene have a higher risk of developing sepsis in the
Chinese Han population.
￿ Single-nucleotide polymorphism (SNP) rs5743867
influences the expression of TOLLIP mRNA and the
production of tumor necrosis factor-alpha and inter-
leukin-6.
￿ Tag SNPs of TLR2, TLR4,T LR9,a n dMyD88 are
not associated with sepsis susceptibility in the Chi-
nese Han population.
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